Of interest, a patient with KCNJ11-TNDM with diabetes onset in 2022 entered remission without any insulin or sulfonylurea treatment, confirming an observation we made in 2 other patients with TNDM associated with KCNJ11 pathogenic variants (5). This evidence concerns the gene KCNJ11 and transient neonatal diabetes mellitus.